Explore

Scientists Reverse Alzheimer's-like Disease in Mice Using CAR-T Cell Therapy

Scientists Reverse Alzheimer's-like Disease in Mice Using CAR-T Cell Therapy

Scientists have successfully reversed Alzheimer's-like disease in mouse models through the use of CAR-T cell therapy, a treatment typically associated with cancer. The research, published in PNAS, involved engineering CD4+ T cells to target and destroy fibrillar amyloid-beta, the toxic protein responsible for plaques in Alzheimer's brains. Unlike existing FDA-approved antibody therapies that offer marginal cognitive effects and carry risks like brain swelling, this CAR-T approach aims to reprogram the brain's immune system. The engineered helper T cells not only reduced brain pathology but also recruited additional immune cells into the brain, reshaping the central nervous system's immune landscape. This method focuses on calming the inflammatory response around plaques rather than solely clearing them. While promising, this is preclinical research, and human trials are still years away. The manufacturing of CAR-T cells is expensive, and the blood-brain barrier presents a unique challenge not found in bloo...

NewAmsterdam Pharma Initiates Phase 2b Clinical Trial for Alzheimer's Drug Targeting Biomarker Reduction

NewAmsterdam Pharma Initiates Phase 2b Clinical Trial for Alzheimer's Drug Targeting Biomarker Reduction

NewAmsterdam Pharma has enrolled the first participant in its Phase 2b clinical trial for an Alzheimer's drug. The trial aims to assess whether a year of treatment can lower Alzheimer's biomarkers in individuals who exhibit disease hallmarks but are currently asymptomatic. The company is developing obicetrapib, a cholesteryl ester transfer protein (CETP) inhibitor, which functions by preventing cholesterol from being shuttled into low-density lipoprotein (LDL). Previous Phase 3 trials of obicetrapib, conducted in individuals with heart disease or genetic high cholesterol, showed an effect on Alzheimer's blood biomarkers. Specifically, in a subgroup of 1,727 participants carrying the ApoE4 Alzheimer's risk gene, the drug lowered blood levels of pTau-217, a biomarker used in diagnosing Alzheimer's in cognitively impaired individuals. While the full implications of this biomarker reduction are still being investigated, experts suggest it indicates the drug's ability to reach the brain and alter its physiology...

Machine Learning Model Identifies Key Health Characteristics for High-Risk Alzheimer's Disease in Community Adults

Machine Learning Model Identifies Key Health Characteristics for High-Risk Alzheimer's Disease in Community Adults

A new study utilized machine learning to identify individuals at high risk for Alzheimer's disease (AD) among 6,267 community-dwelling adults and pinpointed key health characteristics associated with this risk. Researchers constructed LASSO logistic regression, random forest, and decision tree models, with the random forest model demonstrating the highest discriminative performance. Using SHapley Additive exPlanations (SHAP) analysis, the study identified fruit intake, age, snoring, mean grip strength, and sleep duration as the most influential predictors of AD high-risk status. The analysis also revealed non-linear associations, such as a U-shaped relationship between sleep duration and AD risk (both too little and too much sleep increased risk) and a similar non-linear pattern for mean grip strength. These findings suggest that routinely collected community health data can be used for early risk stratification.

UT Health San Antonio Study Shows Significant Combat PTSD Symptom Reduction with Magnetic Stimulation

UT Health San Antonio Study Shows Significant Combat PTSD Symptom Reduction with Magnetic Stimulation

A study conducted by UT Health San Antonio, led by neurologist Dr. Peter Fox, has found that transcranial magnetic stimulation (TMS) significantly reduces symptoms of combat-related Post-Traumatic Stress Disorder (PTSD). The research involved 119 active-duty military personnel and veterans with combat PTSD, who were part of a 30-day residential program. Participants were divided into two groups: one received navigated TMS therapy alongside prolonged exposure therapy, while the other received a 'sham' TMS treatment with prolonged exposure therapy. The study, published in JAMA Network Open, revealed that 85% of the TMS group experienced significant symptom relief by the study's conclusion, compared to 60% in the sham group. Three months later, 75% of the TMS group maintained clinically significant symptom improvement, versus 30% in the sham group. Dr. Fox's team utilized patented, MRI-guided, robotic-controlled TMS to target aberrant brain circuitry with electromagnetic fields, disrupting neural activity to ...

Study Links Positive Early Parenting to Enhanced Joy and Mental Health in Children

Study Links Positive Early Parenting to Enhanced Joy and Mental Health in Children

A 15-year longitudinal study led by Notre Dame psychologist Kaylin Hill has found a significant correlation between positive parenting behaviors in early childhood and a child's ability to experience joy and satisfaction throughout adolescence. The research, published in Communications Psychology, observed interactions between 3-year-old children and their parents, coding for positive behaviors like warmth and encouragement, and negative behaviors such as harshness. These observations were then compared with the development of neural reward responsiveness in the same children at ages 9, 12, 15, and 18. The study, which included 465 young people and their parents at Stony Brook University in New York, utilized electroencephalograms (EEGs) to measure the brain's electrical activity in response to rewarding stimuli, specifically winning a guessing game for money. The findings indicate that children who experienced more positive parenting at age 3 showed a larger brain reward response during adolescence, sugge...

Feinstein Institutes Launches Clinical Trial for Lupus Treatment Using Vagus Nerve Stimulation

Feinstein Institutes Launches Clinical Trial for Lupus Treatment Using Vagus Nerve Stimulation

The Feinstein Institutes for Medical Research has initiated a new clinical trial to investigate the efficacy of non-invasive vagus nerve stimulation (VNS) in treating pain and fatigue associated with systemic lupus erythematosus (SLE). Dr. Cynthia Aranow, a professor in the Institute of Molecular Medicine and Lupus Center of Excellence, is leading the study. Participants in the trial receive daily, brief VNS for 28 days, followed by an additional 28-day monitoring period to assess lasting effects. Researchers are evaluating changes in pain and fatigue levels, as well as monitoring blood biomarkers and the impact of stimulation on the gut microbiome and intestinal permeability. The trial is currently 50 percent enrolled and builds upon Dr. Aranow's previous research, which demonstrated significant reductions in pain and fatigue in lupus patients using transcutaneous VNS. This research is supported by a $450,000 Translational Bridge Award from the Lupus Research Alliance.

Northwestern Medicine Debunks 'Left Brain vs. Right Brain' Myth, Emphasizes Whole Brain Function

Northwestern Medicine Debunks 'Left Brain vs. Right Brain' Myth, Emphasizes Whole Brain Function

Northwestern Medicine has addressed the popular misconception that individuals are either 'left-brained' (logical) or 'right-brained' (creative). According to their updated information, this idea is largely a myth. Research, including studies using magnetic resonance imaging (MRI), indicates that most daily tasks and cognitive functions require both hemispheres of the brain to work together. While certain functions may be more closely linked to one side (e.g., language to the left hemisphere, spatial thinking to the right), the brain operates as an interconnected system, with constant communication between its different regions. A 2013 study from the University of Utah, which reviewed over 1,000 brain scans, found no evidence that people favor one side of the brain overall.

Dietary Choices Impact Brain Health and Mood, Influencing Cognitive Performance and Emotional Stability

Dietary Choices Impact Brain Health and Mood, Influencing Cognitive Performance and Emotional Stability

Dietary Choices Impact Brain Health and Mood, Influencing Cognitive Performance and Emotional Stability

Study Reveals Distinct Health Profile for Early-Onset Alzheimer's Disease

A recent study conducted by the University of Oulu and the University of Eastern Finland has identified that individuals diagnosed with Alzheimer's disease before the age of 65 exhibit a unique set of health problems in the years leading up to their diagnosis. Unlike late-onset Alzheimer's, which is often linked to cardiovascular risk factors, early-onset cases show no increased prevalence of high blood pressure or hyperlipidemia. Instead, researchers observed a rise in conditions such as depression, dizziness, headaches, traumatic brain injuries, epilepsy, cerebrovascular disorders, thyroid diseases, and issues related to heavy alcohol use, particularly in the five years preceding diagnosis. Tinnitus and hearing loss were also found to be more common six to ten years before diagnosis. The study, published in the journal Alzheimer's & Dementia, analyzed data from 407 individuals with early-onset Alzheimer's and over 4,000 age- and sex-matched controls, drawing from memory clinics at Oulu University Hospita...

Salmon Outperforms Fish Oil Supplements for Brain Health Due to Broader Nutrient Profile

Salmon Outperforms Fish Oil Supplements for Brain Health Due to Broader Nutrient Profile

Research Explores 'Psychobiotics' and Gut-Brain Axis for Mental Health

Research Explores 'Psychobiotics' and Gut-Brain Axis for Mental Health

The term 'psychobiotics' refers to a research field investigating microbes and other gut-targeted ingredients for their potential effects on the brain and behavior via the gut-brain axis. This concept was first introduced in a 2013 paper by Timothy Dinan, Catherine Stanton, and John Cryan, defining psychobiotics as live organisms that could offer mental health benefits. While initially focused on probiotics, the term has since broadened to include prebiotics and other substances influencing gut microbes. The gut and brain communicate through various pathways, including nerves like the vagus nerve, hormones, immune signals, and compounds produced by gut microbes. Psychobiotic research aims to determine if altering gut microbes can impact these communication routes. However, much of the early research has been conducted in animals, and human evidence remains limited. It's crucial to note that 'psychobiotic' is a research term and not an official regulatory category for products. Supplements in the U.S. canno...

Neuroticism Linked to Persistent Mental Distress During COVID-19 Pandemic

Neuroticism Linked to Persistent Mental Distress During COVID-19 Pandemic

A new study led by researchers from the University of Southern California (USC) has found that U.S. adults with higher levels of neuroticism experienced greater and more persistent increases in mental distress during the COVID-19 pandemic. Neuroticism is a personality trait characterized by worry, emotional sensitivity, and stronger reactions to stress. The findings, published in PLOS One, analyzed survey responses from 4,030 U.S. adults who participated in the Understanding America Study from 2019 through February 2024, allowing for comparisons of mental health before, during, and after the pandemic. The study examined the 'Big Five' personality traits: neuroticism, extraversion, openness, agreeableness, and conscientiousness. Mental distress was measured using the Patient Health Questionnaire for depression and anxiety symptoms. Participants in the highest quartile for neuroticism experienced 11 to 20 percentage points higher increases in the probability of moderate or severe distress compared to those i...